Nivolumab with gemcitabine plus cisplatin for biliary cancers: as easy as ABC?

被引：2
|
作者：
Franses, Joseph W. [1 ,2 ,3 ]
Hong, Theodore S. [1 ,2 ]
Zhu, Andrew X. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02114 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2019年 / 4卷 / 08期
关键词：
TRACT CANCER; PEMBROLIZUMAB;
D O I：
10.1016/S2468-1253(19)30148-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：575 / 577
页数：4
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF GEMCITABINE PLUS CISPLATIN CHEMOTHERAPY FOR ADVANCED BILIARY TRACT CANCER: A RETROSPECTIVE STUDY
    Hirano, G.
    Takii, Y.
    Kamihira, T.
    Fujisawa, K.
    Ichiki, Y.
    Suzuki, T.
    Matsuo, T.
    Uraoka, S.
    Aoki, K. -I.
    Sakai, K. -I.
    Ogawa, R.
    Higuchi, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 121 - 121
  • [42] Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers
    Ali Ogul
    Mehmet Mutlu Kidi
    Mahmut Buyuksimsek
    Journal of Gastrointestinal Cancer, 2021, 52 : 294 - 299
  • [43] Gemcitabine plus cisplatin and S-1 for biliary tract cancer: a single institute analysis
    Maeda, Osamu
    Shimokata, Tomoya
    Mizutani, Takefumi
    Inoue, Megumi
    Matsuoka, Ayumu
    Ota, Akiko
    Mizuno, Takashi
    Ebata, Tomoki
    Nagino, Masato
    Ando, Yuichi
    ANNALS OF ONCOLOGY, 2017, 28 : 50 - 50
  • [44] Gemcitabine plus capecitabine in biliary cancer
    Nature Clinical Practice Oncology, 2005, 2 (6): : 279 - 280
  • [45] Gemcitabine plus capecitabine in biliary cancer
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 (6): : 253 - 253
  • [46] Prognostic impact of combination therapy with gemcitabine and cisplatin plus S-1 and subsequent conversion surgery for initially unresectable upper biliary tract cancers
    Kosaka, Hisashi
    Matsui, Kosuke
    Ikeura, Tsukasa
    Ito, Takashi
    Ohe, Chisato
    Kono, Yumiko
    Matsushima, Hideyuki
    Yamamoto, Hidekazu
    Sekimoto, Mitsugu
    Kaibori, Masaki
    SURGERY TODAY, 2025, 55 (03) : 351 - 359
  • [47] Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab
    Rimini, Margherita
    Loi, Eleonora
    Rizzato, Mario Domenico
    Pressiani, Tiziana
    Vivaldi, Caterina
    Gusmaroli, Eleonora
    Antonuzzo, Lorenzo
    Martinelli, Erika
    Garajova, Ingrid
    Giordano, Guido
    Lucchetti, Jessica
    Schirripa, Marta
    Cornara, Noemi
    Rossari, Federico
    Vitiello, Francesco
    Amadeo, Elisabeth
    Persano, Mara
    Piva, Vittoria Matilde
    Balsano, Rita
    Salani, Francesca
    Pircher, Chiara
    Cascinu, Stefano
    Niger, Monica
    Fornaro, Lorenzo
    Rimassa, Lorenza
    Lonardi, Sara
    Scartozzi, Mario
    Zavattari, Patrizia
    Casadei-Gardini, Andrea
    TARGETED ONCOLOGY, 2024, 19 (02) : 223 - 235
  • [48] Efficacy and safety of cisplatin and gemcitabine (CG) chemotherapy for advanced biliary tract cancer (ABC) in jaundiced patients (pts)
    Lamarca, Angela
    Benafif, Sarah
    Bridgewater, John A.
    Ross, Paul J.
    Valle, Juan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [49] Gemcitabine, Cisplatin, and Nab-Paclitaxel as a First-Line Therapy for Advanced Biliary Tract Cancers
    Sandeep Gedela
    Pritesh Munot
    Arvind Vaidyanathan
    Ritam Joarder
    Deepali Chaugule
    Manali Parulekar
    Chaitali Nashikkar
    Aayushi Ghadi
    Divya Vadodaria
    Mahesh Goel
    Shraddha Patkar
    Sarika Mandavkar
    Anant Ramaswamy
    Prabhat Bhargava
    Sujay Srinivas
    Vikas Ostwal
    Journal of Gastrointestinal Cancer, 2024, 55 : 263 - 269
  • [50] Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab
    Margherita Rimini
    Eleonora Loi
    Mario Domenico Rizzato
    Tiziana Pressiani
    Caterina Vivaldi
    Eleonora Gusmaroli
    Lorenzo Antonuzzo
    Erika Martinelli
    Ingrid Garajova
    Guido Giordano
    Jessica Lucchetti
    Marta Schirripa
    Noemi Cornara
    Federico Rossari
    Francesco Vitiello
    Elisabeth Amadeo
    Mara Persano
    Vittoria Matilde Piva
    Rita Balsano
    Francesca Salani
    Chiara Pircher
    Stefano Cascinu
    Monica Niger
    Lorenzo Fornaro
    Lorenza Rimassa
    Sara Lonardi
    Mario Scartozzi
    Patrizia Zavattari
    Andrea Casadei-Gardini
    Targeted Oncology, 2024, 19 : 223 - 235
12345